New clinical trials aim to improve EEG applications in various neurological conditions.
- Zeto sponsors clinical trials for EEG research
- Focus on stroke, delirium, and epilepsy
- Pioneering advancements in neurological care
Zeto has announced the winners of its clinical trial sponsorships for 2026, focusing on the advancement of EEG technology. These sponsorships aim to enhance research in critical areas such as stroke, delirium, and epilepsy. By funding these trials, Zeto hopes to improve the applications and effectiveness of EEG in diagnosing and managing these neurological conditions.
The selected trials are designed to explore new methods and technologies in EEG, potentially leading to significant benefits for patients. Each study will address specific challenges associated with the conditions mentioned and is expected to contribute valuable insights into the field. Zeto's initiative reflects a commitment to driving innovation in neurological health.
These sponsorships represent a step toward addressing the urgent needs in the realm of brain health. By supporting research that looks into EEG applications, Zeto aims to spearhead developments that could shift current practices in how neurological disorders are treated and understood.
